Case Report
Type I Cryoglobulinemia With a Fatal Outcome
Crioglobulinemia tipo I de desenlace fatal
Leído
6652
Vecesse ha leído el artículo
2706
Total PDF
3946
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 28 | 9 | 37 |
| 2025 5 | 109 | 32 | 141 |
| 2025 4 | 113 | 27 | 140 |
| 2025 3 | 116 | 17 | 133 |
| 2025 2 | 89 | 28 | 117 |
| 2025 1 | 58 | 34 | 92 |
| 2024 12 | 64 | 29 | 93 |
| 2024 11 | 62 | 39 | 101 |
| 2024 10 | 60 | 36 | 96 |
| 2024 9 | 50 | 19 | 69 |
| 2024 8 | 82 | 47 | 129 |
| 2024 7 | 64 | 36 | 100 |
| 2024 6 | 56 | 28 | 84 |
| 2024 5 | 62 | 24 | 86 |
| 2024 4 | 50 | 26 | 76 |
| 2024 3 | 45 | 34 | 79 |
| 2024 2 | 37 | 38 | 75 |
| 2024 1 | 38 | 40 | 78 |
| 2023 12 | 40 | 23 | 63 |
| 2023 11 | 50 | 44 | 94 |
| 2023 10 | 50 | 35 | 85 |
| 2023 9 | 49 | 34 | 83 |
| 2023 8 | 28 | 27 | 55 |
| 2023 7 | 34 | 42 | 76 |
| 2023 6 | 31 | 25 | 56 |
| 2023 5 | 37 | 23 | 60 |
| 2023 4 | 28 | 22 | 50 |
| 2023 3 | 24 | 26 | 50 |
| 2023 2 | 29 | 30 | 59 |
| 2022 1 | 27 | 34 | 61 |
| 2022 12 | 30 | 40 | 70 |
| 2022 11 | 25 | 26 | 51 |
| 2022 10 | 15 | 41 | 56 |
| 2022 9 | 16 | 51 | 67 |
| 2022 8 | 16 | 35 | 51 |
| 2022 7 | 34 | 32 | 66 |
| 2022 6 | 20 | 26 | 46 |
| 2022 5 | 48 | 37 | 85 |
| 2022 4 | 45 | 40 | 85 |
| 2022 3 | 35 | 44 | 79 |
| 2022 2 | 28 | 42 | 70 |
| 2021 1 | 32 | 37 | 69 |
| 2021 12 | 23 | 38 | 61 |
| 2021 11 | 27 | 48 | 75 |
| 2021 10 | 35 | 53 | 88 |
| 2021 9 | 27 | 45 | 72 |
| 2021 8 | 25 | 29 | 54 |
| 2021 7 | 27 | 29 | 56 |
| 2021 6 | 23 | 37 | 60 |
| 2021 5 | 21 | 19 | 40 |
| 2021 4 | 55 | 65 | 120 |
| 2021 3 | 60 | 15 | 75 |
| 2021 2 | 43 | 29 | 72 |
| 2020 1 | 30 | 18 | 48 |
| 2020 12 | 16 | 11 | 27 |
| 2020 11 | 8 | 17 | 25 |
| 2020 10 | 13 | 10 | 23 |
| 2020 9 | 19 | 9 | 28 |
| 2020 8 | 20 | 18 | 38 |
| 2020 7 | 11 | 13 | 24 |
| 2020 6 | 22 | 26 | 48 |
| 2020 5 | 21 | 18 | 39 |
| 2020 4 | 11 | 15 | 26 |
| 2020 3 | 21 | 25 | 46 |
| 2020 2 | 4 | 7 | 11 |
| 2020 1 | 0 | 5 | 5 |
| 2019 12 | 0 | 14 | 14 |
| 2019 11 | 0 | 4 | 4 |
| 2019 10 | 0 | 5 | 5 |
| 2019 9 | 0 | 1 | 1 |
| 2019 8 | 0 | 7 | 7 |
| 2019 7 | 0 | 8 | 8 |
| 2019 6 | 0 | 8 | 8 |
| 2019 5 | 0 | 42 | 42 |
| 2019 4 | 0 | 10 | 10 |
| 2019 3 | 0 | 10 | 10 |
| 2018 8 | 0 | 2 | 2 |
| 2018 5 | 0 | 1 | 1 |
| 2018 4 | 0 | 3 | 3 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 8 | 2 | 10 |
| 2018 1 | 18 | 5 | 23 |
| 2017 12 | 20 | 13 | 33 |
| 2017 11 | 13 | 1 | 14 |
| 2017 10 | 19 | 8 | 27 |
| 2017 9 | 12 | 6 | 18 |
| 2017 8 | 18 | 8 | 26 |
| 2017 7 | 14 | 6 | 20 |
| 2017 6 | 9 | 4 | 13 |
| 2017 5 | 20 | 5 | 25 |
| 2017 4 | 19 | 10 | 29 |
| 2017 3 | 18 | 8 | 26 |
| 2017 2 | 14 | 8 | 22 |
| 2016 1 | 15 | 11 | 26 |
| 2016 12 | 30 | 3 | 33 |
| 2016 11 | 30 | 27 | 57 |
| 2016 10 | 34 | 20 | 54 |
| 2016 9 | 33 | 6 | 39 |
| 2016 8 | 47 | 10 | 57 |
| 2016 7 | 23 | 7 | 30 |
| 2016 6 | 7 | 0 | 7 |
| 2016 5 | 4 | 8 | 12 |
| 2016 4 | 6 | 0 | 6 |
| 2016 3 | 3 | 0 | 3 |
| 2016 2 | 5 | 1 | 6 |
| 2015 1 | 11 | 2 | 13 |
| 2015 12 | 12 | 0 | 12 |
| 2015 11 | 5 | 0 | 5 |
| 2015 10 | 6 | 4 | 10 |
| 2015 9 | 4 | 1 | 5 |
| 2015 8 | 9 | 2 | 11 |
| 2015 7 | 19 | 9 | 28 |
| 2015 6 | 22 | 3 | 25 |
| 2015 5 | 57 | 17 | 74 |
| 2015 4 | 41 | 20 | 61 |
| 2015 3 | 26 | 18 | 44 |
| 2015 2 | 34 | 9 | 43 |
| 2015 1 | 30 | 7 | 37 |
| 2014 12 | 25 | 7 | 32 |
| 2014 11 | 25 | 9 | 34 |
| 2014 10 | 28 | 15 | 43 |
| 2014 9 | 32 | 10 | 42 |
| 2014 8 | 37 | 17 | 54 |
| 2014 7 | 42 | 14 | 56 |
| 2014 6 | 35 | 12 | 47 |
| 2014 5 | 45 | 10 | 55 |
| 2014 4 | 35 | 18 | 53 |
| 2014 3 | 43 | 13 | 56 |
| 2014 2 | 34 | 15 | 49 |
| 2014 1 | 30 | 19 | 49 |
| 2013 12 | 41 | 8 | 49 |
| 2013 11 | 33 | 21 | 54 |
| 2013 10 | 31 | 13 | 44 |
| 2013 9 | 26 | 27 | 53 |
| 2013 8 | 21 | 20 | 41 |
| 2013 7 | 43 | 28 | 71 |
| 2013 6 | 25 | 19 | 44 |
| 2013 5 | 36 | 21 | 57 |
| 2013 4 | 37 | 30 | 67 |
| 2013 3 | 5 | 10 | 15 |
| 2013 2 | 5 | 7 | 12 |
Mostrar todo
